CTRE vs DOC Stock Comparison
Compare CTRE and DOC across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between CTRE and DOC?
CTRE leads the current stock comparison as CareTrust REIT, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
CareTrust REIT, Inc. vs Healthpeak Properties, Inc.
CTRE leads
CTRE leads by 16 AIQ points, primarily on Quality and Value, and the lead has widened from 7 points over 30 sessions.
Competitive: 4 of 6 evidence groups support CTRE, its lead is widening, and its current signal state is conflicted.
CareTrust REIT, Inc.
Healthpeak Properties, Inc.
The Algovestiq AIQ Score currently favors CTRE over DOC, 50 versus 34 as of Sep 11, 2026. CTRE's advantage is driven primarily by stronger quality and value, while DOC holds the stronger risk resilience profile. CTRE also shows the stronger technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor CTRE today, and the comparison is rated Competitive on stability: the lead has swung materially session to session. CTRE lead: Strengthening — the AIQ differential moved from 7 to 16 points over 30 sessions.
Compare CareTrust REIT, Inc. and Healthpeak Properties, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare CTRE and DOC against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality65 vs 15CTRE +50
- Risk Resilience67 vs 76DOC +9
- Value39 vs 35CTRE +4
- Momentum33 vs 32Even
4 of 6 evidence groups favor CTRE. CTRE’s edge is concentrated in quality and value; DOC keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum -8
New signals
- MACD Bearish Crossover — bearish, momentum, short horizon
Largest factor move: Momentum -10
No new signals fired.
CTRE's lead widened by 1 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — CTRE and DOC both carry a full feed there.
The central trade-off
CTRE (CareTrust REIT, Inc.): the stronger current systematic profile, led by quality and value.
DOC (Healthpeak Properties, Inc.): the counter-case, on risk resilience, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CTRECTRE on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CTRECTRE on combined revenue and EPS growth.
Value
CTRECTRE on the peer-relative Value factor, by 4 points.
Momentum
EvenThe two are level on Momentum.
Lower downside
DOCDOC on Risk Resilience, by 9 points.
Analyst upside
CTRECTRE on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | CTRE | DOC | Note |
|---|---|---|---|
| Implied upside to target | +15% | +5.5% | CTRE has more room |
| Target dispersion | +9% | +32.7% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 7 | 8 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor CTRE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | CTRE | 50 vs 34 |
| Fundamentals | CTRE | revenue growth 13% vs 2.5%; EPS growth 5.6% vs -71.4%; TTM ROE 8.5% vs 3.3%; gross margin 78% vs 2.5%; operating margin 69.7% vs 17.6% |
| Valuation | CTRE | Value 39 vs 35 |
| Technicals | DOC | Price vs 50-day -4.9% vs -5.5%; vs 200-day -0.5% vs 9.2% |
| Risk Resilience | DOC | Risk Resilience 67 vs 76 |
| Analyst expectations | CTRE | Target upside 15% vs 5.5% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CTRE and DOC and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 16 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CTRE.
How the comparison changed
119 daily snapshots · May 4 – Sep 10CTRE lead: Strengthening — the AIQ differential moved from 7 to 16 points over 30 sessions.
- Today
- CTRE +16
- 50 vs 34
- 7 sessions ago
- CTRE +14
- 52 vs 38
- 30 sessions ago
- CTRE +7
- 47 vs 40
- 90 sessions ago
- CTRE +8
- 58 vs 50
The lead changed hands 4 times in this window, most recently on Aug 27 when CTRE moved ahead of DOC.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 1 bearish / 1 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (4.07%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
1 bullish / 1 bearish / 1 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (15.09%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
CTRE leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -0.52%, AIQ -2 points).
Price and the AIQ Score both moved down over the latest session (price -0.34%, AIQ -3 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1DOC closes the Quality gap — currently 50 points behind, the largest single contributor to CTRE's edge.
- 2DOC's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it.
- 3CTRE's conflicting signal state resolves bearish — it currently carries 1 bullish and 1 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
CTRE leads on balance| Metric | CTRE | DOC |
|---|---|---|
| Revenue growth (YoY) | 13% | 2.5% |
| EPS growth (YoY) | 5.6% | -71.4% |
| Gross margin | 78% | 2.5% |
| Operating margin | 69.7% | 17.6% |
| Return on equity (TTM) | 8.5% | 3.3% |
| Debt to equity | 0.27 | 1.32 |
Performance
CTRE leads 4 of 6 windows| Metric | CTRE | DOC |
|---|---|---|
| 1 week (5 sessions) | -1.9% | -3.1% |
| 1 month (20 sessions) | -0.9% | -1.4% |
| 3 months (63 sessions) | 2.9% | -0.5% |
| 6 months (126 sessions) | -2.4% | 19.3% |
| Year to date | 7.4% | 26.7% |
| 1 year (252 sessions) | 12.6% | 11.3% |
Technicals
DOC has the stronger structure| Metric | CTRE | DOC |
|---|---|---|
| RSI (14) | 39.1 | 30.9 |
| ADX (14) | 14.5 | 16.7 |
| Price vs 50-day | -4.9% | -5.5% |
| Price vs 200-day | -0.5% | 9.2% |
| Volatility (1M, annualized) | 15.7% | 16.7% |
Risk
DOC is the more resilient| Metric | CTRE | DOC |
|---|---|---|
| Beta | 0 | 0.42 |
| Sharpe ratio | 0.51 | 0.42 |
| Sortino ratio | 0.75 | 0.81 |
| Max drawdown | -14.3% | -18.5% |
| Current drawdown | -10.6% | -10.7% |
| Annualized volatility | 25.1% | 28.9% |
| Value at risk (95%) | -2.4% | -2.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CTRE or DOC?
On the Algovestiq AIQ Score, CTRE is the stronger of the two as of Sep 11, 2026, scoring 50 against DOC's 34. The edge comes from quality and value. DOC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CTRE or DOC the better buy right now?
CTRE carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor CTRE over DOC?
The composite weights Quality, Value, Momentum and Risk Resilience. CTRE leads Quality by 50 points; DOC leads Risk Resilience by 9 points; CTRE leads Value by 4 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CTRE or DOC?
Analyst price targets imply +15% upside for CTRE and +5.5% for DOC, so the Street currently favors CTRE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CTRE or DOC?
CTRE is the better-valued of the two on the peer-relative Value factor. CTRE on the peer-relative Value factor, by 4 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CTRE or DOC?
CTRE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CTRE or DOC?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CTRE or DOC?
DOC is the more resilient of the two, so the other name carries the higher downside risk. DOC on Risk Resilience, by 9 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CTRE more profitable than DOC?
CTRE leads on the comparable margin measures — gross margin 78% vs 2.5%; operating margin 69.7% vs 17.6%; ttm roe 8.5% vs 3.3%.
Is CTRE's lead over DOC getting stronger or weaker?
CTRE lead: Strengthening — the AIQ differential moved from 7 to 16 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 4 times in that window, most recently on 2026-08-27, when CTRE moved ahead of DOC.
What would change the CTRE vs DOC verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DOC closes the Quality gap — currently 50 points behind, the largest single contributor to CTRE's edge; DOC's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it; CTRE's conflicting signal state resolves bearish — it currently carries 1 bullish and 1 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about CTRE and DOC?
CTRE: 1 bullish / 1 bearish / 1 neutral, conflicted. DOC: 1 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CTRE is Golden Cross Active (bullish, long horizon). On DOC it is Golden Cross Active (bullish, long horizon).
Compare CTRE and DOC with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.